Today's signals · Golden cross, VCP, MACD bullish cross
Signal details →Xilio Therapeutics last closed at $9.11 (+1.11%) on 2026-10-05. Signals today: Golden cross, VCP, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -8.1×. Its overall grade ranks 98 of 741 stocks in Healthcare.
About this company
Xilio Therapeutics last closed at $9.11 (+1.11%) on 2026-10-05. Signals today: Golden cross, VCP, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 98/741
Valuation grade A-
Related stocks
- RocheCustomer
Xilio의 종양면역/면역항암 후보물질 파이프라인의 잠재적 협업·기술이전 상대
- Bristol Myers SquibbCompetitor
면역항암제·종양 치료제 개발에서 경쟁하는 대형 제약사
- MerckCompetitor
PD-1 기반 면역항암 치료제 시장의 핵심 경쟁사
About Xilio Therapeutics
- What technical signals does Xilio Therapeutics (XLO) have?
- Xilio Therapeutics current technical signals: golden cross (5_20, 0d ago).
- Is Xilio Therapeutics a cup-and-handle pattern?
- No. Xilio Therapeutics has no valid Cup signal right now.
- What published figures are available for Xilio Therapeutics?
- Market cap: $34.15M. Trailing 12 months PER: -8.1×. Latest quarter PBR: 2.45×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Xilio Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.